News

Find News

Filter articles

Showing 21 to 30 of 3116 results

Novartis MS drug appeal upheld in Australia

Australia13-10-2020Sarah Morgan

The Federal Court of Australia has backed Novartis’ appeal against a decision revoking its patent covering a multiple sclerosis drug.

Moderna won’t enforce COVID-19 patents

International12-10-2020Muireann Bolger

Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.

Australian court rejects cattle genome patent appeal

Australia12-10-2020Sarah Morgan

The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia.

US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks

US08-10-2020Muireann Bolger

US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.

South Africa, India urge WTO to waive IP for COVID-19 treatments

India, International, South Africa08-10-2020Muireann Bolger

South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.

Two female CRISPR scientists win Nobel Prize in historic first

International08-10-2020Muireann Bolger

French microbiologist Emmanuelle Charpentier and US biochemist Jennifer Doudna have achieved scientific history by jointly winning the Nobel Prize in chemistry for their seminal work on gene-editing technology, CRISPR.

Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms

US06-10-2020Muireann Bolger

Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein.

BMS boosts cardio portfolio with $13bn buy

US06-10-2020Sarah Morgan

Bristol Myers Squibb has announced it will acquire biotech firm MyoKardia for $13.1 billion, strengthening its portfolio of heart disease treatments.

Fed Circuit reinstates $235m verdict against Teva

US06-10-2020Sarah Morgan

In a victory for GlaxoSmithKline, the US Court of Appeals for the Federal Circuit has revived a 2017 jury verdict ordering Teva to pay $235 million over the drug Coreg.

FTC’s $448m AbbVie win overturned

US02-10-2020Rory O'Neill

A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission.

Showing 21 to 30 of 3116 results

LSIPR